Open Access
Open access
Ca-A Cancer Journal for Clinicians, volume 68, issue 6, pages 394-424

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray F I 1
Ferlay Jaques 2
Soerjomataram Isabelle 3
Siegel Rebecca L. 4
Torre Lindsey A 5
Jemal Ahmedin 6
1
 
Head, Section of Cancer Surveillance, International Agency for Research on Cancer; Lyon France
2
 
Informatics Officer, Section of Cancer Surveillance, International Agency for Research on Cancer; Lyon France
3
 
Deputy Head, Section of Cancer Surveillance, International Agency for Research on Cancer; Lyon France
4
 
Scientific Director; Surveillance and Health Services Research, American Cancer Society; Atlanta GA
5
 
Scientist, Surveillance and Health Services Research, American Cancer Society; Atlanta GA
6
 
Scientific Vice President; Surveillance and Health Services Research, American Cancer Society; Atlanta GA
Publication typeJournal Article
Publication date2018-09-12
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor254.7
ISSN00079235, 15424863
Oncology
Hematology
Abstract
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.

Citations by journals

500
1000
1500
2000
2500
Frontiers in Oncology
Frontiers in Oncology, 2118, 3.98%
Frontiers in Oncology
2118 publications, 3.98%
Cancers
Cancers, 1560, 2.93%
Cancers
1560 publications, 2.93%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 802, 1.51%
International Journal of Molecular Sciences
802 publications, 1.51%
Scientific Reports
Scientific Reports, 765, 1.44%
Scientific Reports
765 publications, 1.44%
BMC Cancer
BMC Cancer, 699, 1.31%
BMC Cancer
699 publications, 1.31%
Oncology Letters
Oncology Letters, 526, 0.99%
Oncology Letters
526 publications, 0.99%
Medicine (United States)
Medicine (United States), 522, 0.98%
Medicine (United States)
522 publications, 0.98%
Cancer Medicine
Cancer Medicine, 441, 0.83%
Cancer Medicine
441 publications, 0.83%
Frontiers in Genetics
Frontiers in Genetics, 428, 0.8%
Frontiers in Genetics
428 publications, 0.8%
Cancer Management and Research
Cancer Management and Research, 424, 0.8%
Cancer Management and Research
424 publications, 0.8%
Aging
Aging, 383, 0.72%
Aging
383 publications, 0.72%
BioMed Research International
BioMed Research International, 338, 0.63%
BioMed Research International
338 publications, 0.63%
Cancer Cell International
Cancer Cell International, 333, 0.63%
Cancer Cell International
333 publications, 0.63%
Frontiers in Pharmacology
Frontiers in Pharmacology, 330, 0.62%
Frontiers in Pharmacology
330 publications, 0.62%
Frontiers in Immunology
Frontiers in Immunology, 327, 0.61%
Frontiers in Immunology
327 publications, 0.61%
PLoS ONE
PLoS ONE, 322, 0.6%
PLoS ONE
322 publications, 0.6%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 309, 0.58%
Frontiers in Cell and Developmental Biology
309 publications, 0.58%
Annals of Translational Medicine
Annals of Translational Medicine, 295, 0.55%
Annals of Translational Medicine
295 publications, 0.55%
Molecules
Molecules, 292, 0.55%
Molecules
292 publications, 0.55%
OncoTargets and Therapy
OncoTargets and Therapy, 259, 0.49%
OncoTargets and Therapy
259 publications, 0.49%
Translational Cancer Research
Translational Cancer Research, 243, 0.46%
Translational Cancer Research
243 publications, 0.46%
Journal of Clinical Medicine
Journal of Clinical Medicine, 236, 0.44%
Journal of Clinical Medicine
236 publications, 0.44%
Journal of Oncology
Journal of Oncology, 235, 0.44%
Journal of Oncology
235 publications, 0.44%
Cell Death and Disease
Cell Death and Disease, 230, 0.43%
Cell Death and Disease
230 publications, 0.43%
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, 229, 0.43%
Biomedicine and Pharmacotherapy
229 publications, 0.43%
International Journal of Cancer
International Journal of Cancer, 226, 0.42%
International Journal of Cancer
226 publications, 0.42%
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 220, 0.41%
Journal of Cancer Research and Clinical Oncology
220 publications, 0.41%
Cells
Cells, 203, 0.38%
Cells
203 publications, 0.38%
Oncology Reports
Oncology Reports, 202, 0.38%
Oncology Reports
202 publications, 0.38%
500
1000
1500
2000
2500

Citations by publishers

2000
4000
6000
8000
10000
12000
Springer Nature
Springer Nature, 10176, 19.12%
Springer Nature
10176 publications, 19.12%
Elsevier
Elsevier, 8027, 15.08%
Elsevier
8027 publications, 15.08%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 5138, 9.65%
Multidisciplinary Digital Publishing Institute (MDPI)
5138 publications, 9.65%
Wiley
Wiley, 4695, 8.82%
Wiley
4695 publications, 8.82%
Frontiers Media S.A.
Frontiers Media S.A., 4351, 8.17%
Frontiers Media S.A.
4351 publications, 8.17%
Taylor & Francis
Taylor & Francis, 1656, 3.11%
Taylor & Francis
1656 publications, 3.11%
Wolters Kluwer Health
Wolters Kluwer Health, 1458, 2.74%
Wolters Kluwer Health
1458 publications, 2.74%
AME Publishing Company
AME Publishing Company, 1275, 2.4%
AME Publishing Company
1275 publications, 2.4%
Hindawi Limited
Hindawi Limited, 1246, 2.34%
Hindawi Limited
1246 publications, 2.34%
Spandidos Publications
Spandidos Publications, 1161, 2.18%
Spandidos Publications
1161 publications, 2.18%
Dove Medical Press
Dove Medical Press, 1115, 2.09%
Dove Medical Press
1115 publications, 2.09%
SAGE
SAGE, 840, 1.58%
SAGE
840 publications, 1.58%
Baishideng Publishing Group
Baishideng Publishing Group, 482, 0.91%
Baishideng Publishing Group
482 publications, 0.91%
American Chemical Society (ACS)
American Chemical Society (ACS), 443, 0.83%
American Chemical Society (ACS)
443 publications, 0.83%
Impact Journals
Impact Journals, 435, 0.82%
Impact Journals
435 publications, 0.82%
BMJ
BMJ, 428, 0.8%
BMJ
428 publications, 0.8%
Bentham Science
Bentham Science, 419, 0.79%
Bentham Science
419 publications, 0.79%
Oxford University Press
Oxford University Press, 414, 0.78%
Oxford University Press
414 publications, 0.78%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 398, 0.75%
American Association for Cancer Research (AACR)
398 publications, 0.75%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 380, 0.71%
Royal Society of Chemistry (RSC)
380 publications, 0.71%
Future Medicine
Future Medicine, 377, 0.71%
Future Medicine
377 publications, 0.71%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 348, 0.65%
Public Library of Science (PLoS)
348 publications, 0.65%
Mary Ann Liebert
Mary Ann Liebert, 235, 0.44%
Mary Ann Liebert
235 publications, 0.44%
S. Karger AG
S. Karger AG, 193, 0.36%
S. Karger AG
193 publications, 0.36%
IEEE
IEEE, 175, 0.33%
IEEE
175 publications, 0.33%
Thieme
Thieme, 165, 0.31%
Thieme
165 publications, 0.31%
Hans Publishers
Hans Publishers, 159, 0.3%
Hans Publishers
159 publications, 0.3%
PeerJ
PeerJ, 135, 0.25%
PeerJ
135 publications, 0.25%
Walter de Gruyter
Walter de Gruyter, 134, 0.25%
Walter de Gruyter
134 publications, 0.25%
2000
4000
6000
8000
10000
12000
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Bray F. I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // Ca-A Cancer Journal for Clinicians. 2018. Vol. 68. No. 6. pp. 394-424.
GOST all authors (up to 50) Copy
Bray F. I., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // Ca-A Cancer Journal for Clinicians. 2018. Vol. 68. No. 6. pp. 394-424.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3322/caac.21492
UR - https://doi.org/10.3322%2Fcaac.21492
TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
T2 - Ca-A Cancer Journal for Clinicians
AU - Bray, F I
AU - Ferlay, Jaques
AU - Soerjomataram, Isabelle
AU - Siegel, Rebecca L.
AU - Torre, Lindsey A
AU - Jemal, Ahmedin
PY - 2018
DA - 2018/09/12 00:00:00
PB - Wiley
SP - 394-424
IS - 6
VL - 68
SN - 0007-9235
SN - 1542-4863
ER -
BibTex |
Cite this
BibTex Copy
@article{2018_Bray
author = {F I Bray and Jaques Ferlay and Isabelle Soerjomataram and Rebecca L. Siegel and Lindsey A Torre and Ahmedin Jemal},
title = {Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries},
journal = {Ca-A Cancer Journal for Clinicians},
year = {2018},
volume = {68},
publisher = {Wiley},
month = {sep},
url = {https://doi.org/10.3322%2Fcaac.21492},
number = {6},
pages = {394--424},
doi = {10.3322/caac.21492}
}
MLA
Cite this
MLA Copy
Bray, F. I., et al. “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.” Ca-A Cancer Journal for Clinicians, vol. 68, no. 6, Sep. 2018, pp. 394-424. https://doi.org/10.3322%2Fcaac.21492.
Found error?